Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment [Phase 2, Phase 3]
Phase II/III study evaluating Tumor Treating Fields (EFE-P100) with docetaxel for stage IV non-small cell lung cancer after progression on p…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Milciclib in Combination With Gemcitabine in Advanced NSCLC [Phase 2]
Phase 2 trial update for milciclib in combination with gemcitabine in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial [Phase 3]
A phase 3 single-center trial investigating first-line treatment for advanced non-squamous non-small-cell lung cancer without driver mutatio…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) [Phase 2]
Phase 2 trial evaluating durvalumab with olaparib, or durvalumab after prior durvalumab plus chemotherapy, in non-small cell lung cancer; th…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety trial of GEN1029 (HexaBody-DR5/DR5) in malignant solid tumors (termina ted; results posted in 2022).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update investigating hydroxychloroquine in combination with gemcitabine for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating imaging of tumor-infiltrating T-cells in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Phase II Umbrella Study Directed by Next Generation Sequencing [Phase 2]
Phase II umbrella study in non-small cell lung cancer run under next-generation sequencing guidance; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, and anti-tumor activity of AZD3759 in non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating camrelizumab plus famitinib malate in treatment-naïve PD-L1-positive recurrent or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer [Phase 3]
Phase 3 trial updating REGN2810 plus platinum-based chemotherapy and ipilimumab versus pembrolizumab monotherapy in non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC [Phase 2]
Phase 2 trial evaluating camrelizumab with AC chemotherapy in brain metastases from driven gene-negative non-squamous non-small-cell lung ca…
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782) [Phase 2]
Phase 2 clinical trial evaluating biomarkers of response to pembrolizumab plus chemotherapy in non-small cell lung cancer; results have been…
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study [Phase 3]
Phase 3 trial evaluating pembrolizumab with or without lenvatinib in PD-L1-positive treatment-naïve non-small cell lung cancer; China extens…
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial [Phase 2, Phase 3]
A randomized trial evaluating a PD-1 antibody in addition to BACE in non-small cell lung cancer, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update on surufatinib combined with toripalimab and chemotherapy for non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer [Phase 2]
Phase 2 trial of REGN2810 (cemiplimab) in combination with ipilimumab for advanced non-small cell lung carcinoma has been terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799) [Phase 2]
This Phase 2 trial (KEYNOTE-799) evaluated pembrolizumab in combination with chemotherapy and radiotherapy for stage III non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) [Phase 2]
Phase 2 trial exploring vinorelbine metronomic chemotherapy with hypofractionated radiotherapy followed by PD-1/PD-L1 sequential GM-CSF and …
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen [Phase 3]
A Phase 3 safety trial of nivolumab in advanced or metastatic non-small cell lung cancer after prior chemotherapy has completed with results…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations [Phase 2]
Phase 2 clinical trial update for Ningetinib in advanced non-small cell lung cancer with MET exon 14 skipping mutations.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiotherapy followed by hypo-boost for local advanced non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) [NA]
Clinical trial update for S1415CD (TrACER) reporting completed status with results posted; study involves CSF prescribing effectiveness and …
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer [Phase 1, Phase 2]
A dose-escalation trial is investigating hypofractionated stereotactic radiotherapy for brain metastases in patients with non-small cell lun…